Profile data is unavailable for this security.
About the company
Biocytogen Pharmaceuticals Beijing Co Ltd is a company mainly engaged in drug development business and preclinical research. The Company operates its business through five segments. The Gene-Editing services segment provides the customized gene-editing services based on animals as well as cells. The Pre-clinical Pharmacology and Efficacy Evaluation segment provides preclinical pharmacology services for the evaluation of drug efficacy and toxicity. The Animal Models Selling segment breeds and sells the animal models for the external and internal use. The Antibody Development segment utilises its antibody discovery platforms to identify antibodies which have the potential to become drug candidates. The Innovative Drugs Development segment is engaged in research and development of innovative drugs with a focus on oncology and autoimmune disease therapeutics. The Company also conducts its business through the Other segment.
- Revenue in HKD (TTM)775.88m
- Net income in HKD-414.45m
- Incorporated2009
- Employees1.07k
- LocationBiocytogen Pharmaceuticals Beijing Co LtdNo. 12Baocan South Street, Daxing DistrictBeijing 101111ChinaCHN
- Phone+86 1 056967666
- Fax+86 1 056315306
- Websitehttps://www.biocytogen.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbisko Cayman Ltd | 20.63m | -467.08m | 2.42bn | 258.00 | -- | 1.13 | -- | 117.44 | -0.7217 | -0.7217 | 0.0319 | 3.06 | 0.0083 | -- | 1.40 | 79,951.98 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
| Peijia Medical Ltd | 477.41m | -424.81m | 2.49bn | 1.04k | -- | 1.01 | -- | 5.21 | -0.6255 | -0.6255 | 0.7028 | 3.62 | 0.1473 | 0.7773 | 9.51 | 459,045.10 | -13.11 | -34.08 | -14.94 | -36.90 | 73.76 | 71.62 | -88.99 | -448.75 | 6.92 | -- | 0.0886 | -- | 75.86 | -- | 3.75 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 84.45m | 2.50bn | 1.76k | 30.10 | 0.9348 | 6.92 | 1.23 | 0.0409 | 0.0409 | 0.981 | 1.32 | 0.463 | 60.63 | 5.32 | 1,154,294.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Laekna Inc | 0.00 | -399.15m | 2.57bn | 89.00 | -- | 2.95 | -- | -- | -3.31 | -3.31 | 0.00 | 2.23 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
| MicroPort CardioFlow Medtech Corp | 363.87m | -510.32m | 2.75bn | 592.00 | -- | 1.09 | -- | 7.56 | -0.2159 | -0.2159 | 0.154 | 1.05 | 0.1205 | 2.78 | 3.67 | 614,640.80 | -16.91 | -17.37 | -18.11 | -22.96 | 2.06 | -1.67 | -140.25 | -180.82 | 9.91 | -11.56 | 0.0293 | -- | 33.94 | -- | -3.77 | -- | -14.16 | -- |
| Golden Throat Holdings Group Co Ltd | 1.04bn | 270.74m | 2.84bn | 869.00 | 10.49 | 1.69 | 9.07 | 2.73 | 0.3662 | 0.3662 | 1.41 | 2.27 | 0.4181 | 4.82 | 1.85 | 1,197,292.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| HighTide Therapeutics Inc | 0.00 | -594.96m | 3.48bn | 66.00 | -- | 4.20 | -- | -- | -1.26 | -1.26 | -- | 1.61 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.3798 | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
| China Isotope & Radiation Corp | 7.18bn | 401.48m | 3.52bn | 3.11k | 8.76 | 0.6927 | 3.24 | 0.49 | 1.26 | 1.26 | 22.45 | 15.88 | 0.5312 | 4.22 | 1.84 | 2,312,623.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -809.30m | 3.55bn | 516.00 | -- | 1.82 | -- | -- | -1.46 | -1.46 | 0.00 | 3.39 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 775.88m | -414.45m | 3.89bn | 1.07k | -- | 4.58 | -- | 5.02 | -1.04 | -1.04 | 1.95 | 2.13 | 0.2732 | 16.21 | 5.74 | 727,837.90 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 4.37bn | 1.93k | 254.19 | 1.04 | 38.57 | 0.8216 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -619.00m | 4.44bn | 472.00 | -- | 3.80 | -- | -- | -1.29 | -1.29 | 0.00 | 2.42 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Ocumension Therapeutics | 266.63m | -411.02m | 4.72bn | 444.00 | -- | 1.48 | -- | 17.71 | -0.6334 | -0.6334 | 0.4107 | 4.57 | 0.078 | 3.61 | 2.12 | 600,517.40 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Alphamab Oncology | 236.77m | -227.91m | 5.05bn | 435.00 | -- | 2.79 | -- | 21.31 | -0.237 | -0.237 | 0.2467 | 1.88 | 0.1028 | 0.7705 | 19.34 | 544,292.60 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Shandong Boan Biotechnology Co Ltd | 668.97m | -129.20m | 5.19bn | 813.00 | -- | 3.64 | -- | 7.77 | -0.2537 | -0.2537 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | 822,838.40 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.80bn | 849.06m | 5.20bn | 3.13k | 5.99 | 1.31 | 5.56 | 1.86 | 1.06 | 1.06 | 3.51 | 4.84 | 0.4981 | 2.08 | 9.10 | 896,431.60 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
Data as of May 10 2024. Currency figures normalised to Biocytogen Pharmaceuticals Beijing Co Ltd's reporting currency: Hong Kong Dollar HKD
